How Much Did YuLife Raise?
Funding & Key Investors

YuLife, a tech-driven insurance company, has secured substantial capital, with its total funding reaching $201M. The company recently announced a significant strategic investment of $120M, underscoring its growth trajectory and market position in the insurtech sector. This latest financing round is expected to fuel further innovation and expansion for the wellness-focused insurance provider.

What is YuLife?

YuLife
Insurance

YuLife operates as an innovative insurance provider, leveraging gamification and behavioral science to encourage healthy living and make financial products a positive force for good. Founded in 2017 and headquartered in London, the company aims to integrate everyday wellness into its insurance offerings. Its unique approach rewards users for healthy habits, positioning it as a forward-thinking player in the insurance technology landscape. The company's mission is to inspire life and foster well-being through its unique product suite.

How much funding has YuLife raised?

YuLife has raised a total of $201M across 3 funding rounds:

2019

Series A

$11M

2021

Series B

$70M

2022

Series C

$120M

Series A (2019): $11M with participation from OurCrowd, RGAX, Anthemis, Creandum Funds, Notion Capital, and MMC Ventures

Series B (2021): $70M led by OurCrowd, MMC Ventures, Target Global, Creandum, Anthemis, Eurazeo, Notion Capital, and Latitude

Series C (2022): $120M supported by Dai-ichi Life Holdings and T. Rowe Price

Key Investors in YuLife

Dai-ichi Life Holdings

Dai-ichi Life Holdings is a major Japanese insurance group with a global presence, likely investing to expand its reach into innovative insurtech solutions and international markets.

T. Rowe Price

T. Rowe Price is a global asset management firm that invests in public equity and fixed income markets, likely participating to support YuLife's scaling and potential IPO.

Target Global

Target Global is a leading pan-European technology investment firm that invests across all stages, likely backing YuLife for its disruptive potential in the insurtech space and its European market traction.

What's next for YuLife?

With a significant enterprise-level funding injection, YuLife is poised for accelerated growth and product development. The recent major strategic investment signals strong investor confidence in its disruptive model. This capital infusion will likely be directed towards enhancing its gamified wellness platform, expanding its market reach, and potentially exploring new insurance verticals. YuLife's focus on integrating health and financial well-being positions it to capitalize on the growing demand for preventative and value-added insurance solutions.

See full YuLife company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Insurance industry

Frequently Asked Questions Regarding YuLife Financial Insights

What are the most recent funding rounds that YuLife has completed, and what were the funding rounds?
YuLife has recently completed 3 funding rounds: Series C on Jul 7, 2022, Series B on Jul 14, 2021, Series A on May 29, 2019.
What is the total amount of funding YuLife has raised to date?
YuLife has raised a total of $201M in funding to date.
How many funding rounds has YuLife completed?
YuLife has completed 3 funding rounds.
How much funding did YuLife raise in its most recent funding round?
YuLife raised $120M in its most recent funding round.
Who are the lead investors in YuLife's latest funding round?
The lead investor in YuLife's latest funding round was Dai-ichi Life Holdings. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in YuLife's history?
The largest funding round in YuLife's history was $120M.
See more information about YuLife